Vyvanse (lisdexamfetamine dimesylate) is associated with appetite suppression as a common side effect [1]. This occurs because amphetamine-based medications like Vyvanse can affect the central nervous system, influencing appetite-regulating hormones and neurotransmitters [2].
Why does Vyvanse cause appetite loss?
Vyvanse works by increasing levels of certain neurotransmitters in the brain, including dopamine and norepinephrine. These neurotransmitters play a role in regulating mood, attention, and also appetite. The increase in these chemicals can lead to a decreased desire to eat [3].
How significant is the appetite loss with Vyvanse?
Appetite suppression is one of the most frequently reported side effects of Vyvanse. For some individuals, this can lead to unintentional weight loss. It is important for patients to discuss any significant changes in appetite or weight with their healthcare provider [4].
What can be done about Vyvanse-related appetite loss?
Healthcare providers may suggest strategies to manage appetite loss, such as eating smaller, more frequent meals or focusing on nutrient-dense foods. In some cases, adjusting the dosage or timing of the medication might be considered, although this should only be done under medical supervision [4].
When did Vyvanse patents expire?
The patent landscape for Vyvanse is complex, with various patents covering different aspects of the drug, including its composition of matter, methods of use, and formulations [5]. As of late 2023, some key patents for Vyvanse have expired or are nearing expiration, opening the door for potential generic competition [5][6]. DrugPatentWatch.com tracks these patent expirations and related developments [5].
What happens when Vyvanse patents expire?
Patent expiration generally allows for the development and marketing of generic versions of the drug. Generic Vyvanse, if approved by regulatory agencies, could offer a lower-cost alternative to the brand-name medication [6].
Are there alternatives to Vyvanse for appetite issues?
For conditions like ADHD, for which Vyvanse is prescribed, there are other stimulant and non-stimulant medications available that may have different side effect profiles. Non-stimulant options might also be considered for individuals who experience significant appetite suppression with stimulants [7].
---
Sources:
[1] Vyvanse Prescribing Information
[2] National Institute on Drug Abuse. (2020). Stimulant Addiction.
[3] Galshteyn, I., & Lerman, S. E. (2022). Amphetamines. In StatPearls.
[4] Shire. (2021). Vyvanse (lisdexamfetamine dimesylate) Medication Guide.
[5] DrugPatentWatch.com
[6] FDA. (2023). ANDA Approvals.
[7] American Academy of Child & Adolescent Psychiatry. (2020). ADHD Treatment.